Corruption News

The Stock That Went From 50 Cents to $260 | The Compound and Friends 78

0



On episode 78 of The Compound and Friends, Michael Batnick and Downtown Josh Brown are joined by Nathan Vardi to discuss Nathan’s book (For Blood and Money), the biotech landscape, hedge fund returns, the stock market GOAT, venture capital, why the market is rallying, and much more!

To learn more about Future Proof, visit: https://www.futureproof.advisorcircle.com/

More from Nathan:
https://twitter.com/nathanvardi

00:00 – Intro
04:26 – For Blood and Money
18:47 – The FDA
22:11 – From 50 cents to $260
28:33 – Biotechs Now
37:08 – Biotech vs. Pharma?
41:05 – Hedge Funds
53:29 – Venture Capital
57:28 – AI / Machine Learning
59:39 – Active vs. Passive
01:03:21 – ChatGPT
01:11:06 – Favorites

👕 Check out The Compound shop: https://www.idontshop.com

🎙️ Listen to our podcasts:
The Compound and Friends: https://link.chtbl.com/compoundandfriends
Animal Spirits: https://podcasts.apple.com/us/podcast/animal-spirits-podcast/id1310192007
Portfolio Rescue: https://link.chtbl.com/totherescue

The Compound Newsletter: https://email.thecompoundnews.com/subscribe

Instagram: https://instagram.com/thecompoundnews
Twitter: https://twitter.com/thecompoundnews
Facebook: https://www.facebook.com/ritholtzwealth

Investing involves the risk of loss. This podcast is for informational purposes only and should not be or regarded as personalized investment advice or relied upon for investment decisions. Michael Batnick and Josh Brown are employees of Ritholtz Wealth Management and may maintain positions in the securities discussed in this video. All opinions expressed by them are solely their own opinion and do not reflect the opinion of Ritholtz Wealth Management.

Wealthcast Media, an affiliate of Ritholtz Wealth Management, receives payment from various entities for advertisements in affiliated podcasts, blogs and emails. Inclusion of such advertisements does not constitute or imply endorsement, sponsorship or recommendation thereof, or any affiliation therewith, by the Content Creator or by Ritholtz Wealth Management or any of its employees. For additional advertisement disclaimers see here https://ritholtzwealth.com/advertising-disclaimers. Investments in securities involve the risk of loss. Any mention of a particular security and related performance data is not a recommendation to buy or sell that security. The information provided on this website (including any information that may be accessed through this website) is not directed at any investor or category of investors and is provided solely as general information.

Obviously nothing on this channel should be considered as personalized financial advice or a solicitation to buy or sell any securities. See our disclosures here: https://ritholtzwealth.com/podcast-youtube-disclosures/

#thecompound #investing #biotech

source

Leave A Reply

Your email address will not be published.